Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gemma Pagès"'
Autor:
Judit Homs, Gemma Pagès, Lorena Ariza, Caty Casas, Miguel Chillón, Xavier Navarro, Assumpció Bosch
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 1, Iss C (2014)
Different adeno-associated virus (AAV) serotypes efficiently transduce neurons from central and peripheral nervous systems through various administration routes. Direct administration of the vectors to the cerebrospinal fluid (CSF) could be an effici
Externí odkaz:
https://doaj.org/article/5c8bb3bb4c094646ac916bdbedb6acfb
Autor:
Assumpció Bosch, Belén García-Lareu, Lydia Giménez-Llort, Lorena Ariza, Miguel Chillón, Caty Casas, Gemma Pagès, Marc Navarro
Publikováno v:
Human Molecular Genetics. 28:3610-3624
Mucopolysaccharidosis (MPS) type VII is a lysosomal storage disease caused by ß-glucuronidase deficiency, prompting glycosaminoglycan accumulation in enlarged vesicles, leading to peripheral and neuronal dysfunction. Here, we present a gene therapy
Autor:
Belén García-Lareu, Assumpció Bosch, Rubèn López-Vales, Xavier Navarro, Sergi Verdés, Miguel Chillón, Gemma Pagès, Mireia Herrando-Grabulosa, Guillem Mòdol-Caballero
Publikováno v:
Neurotherapeutics
Glial cell line–derived neurotrophic factor (GDNF) is a powerful neuroprotective growth factor. However, systemic or intrathecal administration of GDNF is associated with side effects. Here, we aimed to avoid this by restricting the transgene expre
Autor:
Lorena Ariza, Xavier Navarro, Judit Homs, Miguel Chillón, Assumpció Bosch, Gemma Pagès, Esther Udina
Publikováno v:
Gene Therapy. 18:622-630
Efficient transduction of the peripheral nervous system (PNS) is required for gene therapy of acquired and inherited neuropathies, neuromuscular diseases and for pain treatment. We have characterized the tropism and transduction efficiency of differe
Publikováno v:
Gene therapy. 22(2)
Simian adeno-associated virus (AAV) serotype rh.10 is a promising gene therapy tool, achieving safe, sustained transgene expression in the nervous system, lung, liver and heart in animal models. To date, preexisting immunity in humans has not been co
Autor:
Jesús Ruberte, Xavier Navarro, Lorena Ariza, S. Cobianchi, Pedro J. Otaegui, Assumpció Bosch, Gemma Pagès, Belén García-Lareu, Miguel Chillón
Publikováno v:
Neuroscience. 274
Animal models of diabetes do not reach the severity of human diabetic neuropathy but relatively mild neurophysiological deficits and minor morphometric changes. The lack of degenerative neuropathy in diabetic rodent models seems to be a consequence o
Autor:
Lorena Ariza, Lydia Giménez-Llort, Assumpció Bosch, Dan Cots, Eric J. Kremer, Belén García-Lareu, Aurélie Cubizolle, Gemma Pagès, Rosemary Thwaite, Miguel Chillón, Nicolas Serratrice
Publikováno v:
Human Gene Therapy
Human Gene Therapy, 2014, 25 (3), pp.199--211. ⟨10.1089/hum.2013.152⟩
Human Gene Therapy, Mary Ann Liebert, 2014, 25 (3), pp.199--211. ⟨10.1089/hum.2013.152⟩
Human Gene Therapy, 2014, 25 (3), pp.199--211. ⟨10.1089/hum.2013.152⟩
Human Gene Therapy, Mary Ann Liebert, 2014, 25 (3), pp.199--211. ⟨10.1089/hum.2013.152⟩
International audience; Canine adenovirus type 2 vectors (CAV-2) are promising tools to treat global central nervous system (CNS) disorders due to their preferential transduction of neurons and efficient retrograde axonal transport. Here we tested th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::516e66bf8defe1b279b6425a10c179f4
https://hal.science/hal-02191549
https://hal.science/hal-02191549
Autor:
Lorena Ariza, Xavier Navarro, Enrique Verdú, Gemma Pagès, Esther Udina, Miguel Chillón, Assumpció Bosch, Laura Casals, Judit Homs
Publikováno v:
Journal of the peripheral nervous system : JPNS. 16(3)
The non-obese diabetic (NOD) mouse was suggested as an adequate model for diabetic autonomic neuropathy. We evaluated sensory-motor neuropathy and nerve regeneration following sciatic nerve crush in NOD males rendered diabetic by multiple low doses o
Autor:
Caty Casas, Assumpció Bosch, Xavier Navarro, Judit Homs, Lorena Ariza, Gemma Pagès, Miguel Chillón
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 1, Iss C (2014)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Molecular Therapy. Methods & Clinical Development
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Molecular Therapy. Methods & Clinical Development
Altres ajuts: G.P. and L.A. from the Generalitat de Catalunya: 2009FI_B00219 and 2006FI00762, respectively). A.B. was a beneficiary of the Ramon y Cajal Program. This work was supported by the Marató TV3 (110432 to A.B. and C.C.) and the UAB (EME04-